Inherited CARD9 Deficiency in a Patient with Both Exophiala spinifera and Aspergillus nomius Severe Infections.
Aspergillus
/ physiology
CARD Signaling Adaptor Proteins
/ genetics
Candidiasis, Chronic Mucocutaneous
/ diagnosis
Cells, Cultured
Exophiala
/ physiology
Female
Humans
Interleukin-6
/ metabolism
Middle Aged
Mutation
/ genetics
Pedigree
Phaeohyphomycosis
/ diagnosis
Pneumonectomy
Pulmonary Aspergillosis
/ diagnosis
Aspergillus nomius
Chronic invasive pulmonary aspergillosis
Exophiala spinifera
Inherited CARD9 deficiency
Phaeohyphomycosis
Journal
Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
12
11
2019
accepted:
30
12
2019
pubmed:
16
1
2020
medline:
3
7
2021
entrez:
16
1
2020
Statut:
ppublish
Résumé
Caspase-associated recruitment domain-9 (CARD9) deficiency is an inborn error of immunity that typically predisposes otherwise healthy patients to single fungal infections and the occurrence of multiple invasive fungal infections is rare. It has been described as the first known condition that predisposes to extrapulmonary Aspergillus infection with preserved lungs. We present a patient that expands the clinical variability of CARD9 deficiency. Genetic analysis was performed by Sanger sequencing. Neutrophils and mononuclear phagocyte response to fungal stimulation were evaluated through luminol-enhanced chemiluminescence and whole blood production of the proinflammatory mediator interleukin (IL)-6, respectively. We report a 56-year-old Argentinean woman, whose invasive Exophiala spinifera infection at the age of 32 years was unexplained and reported in year 2004. At the age of 49 years, she presented with chronic pulmonary disease due to Aspergillus nomius. After partial improvement following treatment with caspofungin and posaconazole, right pulmonary bilobectomy was performed. Despite administration of multiple courses of antifungals, sustained clinical remission could not be achieved. We recently found that the patient's blood showed an impaired production of IL-6 when stimulated with zymosan. We also found that she is homozygous for a previously reported CARD9 loss-of-function mutation (Q289*). This is the first report of a patient with inherited CARD9 deficiency and chronic invasive pulmonary aspergillosis (IPA) due to A. nomius. Inherited CARD9 deficiency should be considered in otherwise healthy children and adults with one or more invasive fungal diseases.
Identifiants
pubmed: 31940125
doi: 10.1007/s10875-019-00740-2
pii: 10.1007/s10875-019-00740-2
pmc: PMC8315308
mid: NIHMS1629460
doi:
Substances chimiques
CARD Signaling Adaptor Proteins
0
CARD9 protein, human
0
Interleukin-6
0
Types de publication
Case Reports
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
359-366Subventions
Organisme : NIAID NIH HHS
ID : R01 AI127564
Pays : United States
Organisme : NIH HHS
ID : R01AI127564
Pays : United States
Références
Cell Rep. 2012 Dec 27;2(6):1762-73
pubmed: 23200858
Mycoses. 2018 Jan;61(1):61-65
pubmed: 28984994
Front Immunol. 2018 Oct 31;9:2366
pubmed: 30429846
Blood. 2013 Mar 28;121(13):2385-92
pubmed: 23335372
J Mycol Med. 2017 Jun;27(2):250-253
pubmed: 28391957
Eur Respir Rev. 2011 Sep 1;20(121):156-74
pubmed: 21881144
Clin Immunol. 2018 Jun;191:21-26
pubmed: 29307770
Br J Dermatol. 2016 Jan;174(1):176-9
pubmed: 26440558
Clin Infect Dis. 2004 Feb 1;38(3):e15-20
pubmed: 14727230
Free Radic Biol Med. 2010 Dec 15;49(12):1834-45
pubmed: 20870019
J Clin Immunol. 2015 Jul;35(5):486-90
pubmed: 26044242
Curr Opin Pediatr. 2013 Dec;25(6):736-47
pubmed: 24240293
J Clin Immunol. 2016 Apr;36(3):204-9
pubmed: 26961233
Br J Dermatol. 2019 Jan;180(1):213-214
pubmed: 30187457
J Allergy Clin Immunol. 2014 Mar;133(3):905-8.e3
pubmed: 24231284
BMJ Case Rep. 2016 Mar 03;2016:
pubmed: 26941346
Front Cell Infect Microbiol. 2016 Apr 05;6:39
pubmed: 27092298
Acta Derm Venereol. 2011 Sep;91(5):591-2
pubmed: 21874220
Mycopathologia. 2015 Jun;179(5-6):347-57
pubmed: 25790941
J Clin Immunol. 2018 Oct;38(7):794-803
pubmed: 30264381
J Clin Immunol. 2018 Aug;38(6):656-693
pubmed: 30136218
Cold Spring Harb Perspect Med. 2014 Nov 10;5(8):a019570
pubmed: 25384772
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60
pubmed: 27365388
N Engl J Med. 2013 Oct 31;369(18):1704-1714
pubmed: 24131138
Pediatr Infect Dis J. 2016 Apr;35(4):428-31
pubmed: 26658378
Clin Infect Dis. 2014 Jul 1;59(1):81-4
pubmed: 24704721
Thorax. 2015 Mar;70(3):270-7
pubmed: 25354514
J Allergy Clin Immunol. 2016 Apr;137(4):1178-1188.e7
pubmed: 26521038
JAMA Dermatol. 2015 Feb;151(2):192-4
pubmed: 25372963
J Infect Dis. 2015 Apr 15;211(8):1241-50
pubmed: 25057046
Pediatr Infect Dis J. 2015 Sep;34(9):999-1002
pubmed: 25933095
J Clin Microbiol. 2009 Oct;47(10):3382-5
pubmed: 19710265
Rev Chilena Infectol. 2017 Oct;34(5):502-506
pubmed: 29488596
N Engl J Med. 2009 Oct 29;361(18):1727-35
pubmed: 19864672
Med Mycol. 2012 Oct;50(7):746-50
pubmed: 22369623
Clin Infect Dis. 1992 Jan;14(1):235-42
pubmed: 1571438
PLoS Pathog. 2015 Dec 17;11(12):e1005293
pubmed: 26679537
J Invest Dermatol. 2018 Mar;138(3):607-617
pubmed: 29080677
Eur Respir J. 2016 Jan;47(1):45-68
pubmed: 26699723
Rev Iberoam Micol. 2006 Jun;23(2):119-21
pubmed: 16854193
J Allergy Clin Immunol. 2015 Jun;135(6):1558-68.e2
pubmed: 25702837
Front Microbiol. 2017 Dec 19;8:2514
pubmed: 29312215
JCI Insight. 2016 Oct 20;1(17):e89890
pubmed: 27777981
J Infect Dis. 2018 Jul 2;218(3):485-489
pubmed: 29659908